Rwanda vs Singapore: Proportion of the target population who received the final dose of
Rwanda
69.0%
in 2024
Singapore
70.0%
in 2024
Rwanda rank
46th
Singapore rank
44th
Proportion of the target population who received the final dose of over time
- Rwanda
- Singapore
How they compare
Singapore currently reports 70.0% against 69.0% in Rwanda, a difference of 1.0%.
The two have swapped places 3 times across 13 shared years of data; in 2012 it was Rwanda ahead.
Rwanda ranks 46th and Singapore ranks 44th of 107 countries.
Across the 2 decades both report, Rwanda averaged higher in 1 and Singapore in 1.
Head to head by decade
| Decade | Rwanda | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 69.6% | 11.4% | 58.2% | Rwanda |
| 2020s | 56.8% | 74.6% | 17.8% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Rwanda or Singapore?
- Singapore, at 70.0% against 69.0% in Rwanda as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Rwanda and Singapore?
- 1.0%, with Singapore ahead.
- How many years of comparable data are there for Rwanda and Singapore?
- 13 years are reported by both, from 2012 to 2024.
- How do Rwanda and Singapore rank globally for proportion of the target population who received the final dose of?
- Rwanda ranks 46th and Singapore ranks 44th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.